Aurora Cannabis Announces Results of 2021 Annual General Meeting

Rhea-AI Summary

Aurora Cannabis announced the results of its Annual General Meeting held on November 12, 2021, with 60,616,648 shares represented, accounting for 30.6% of its outstanding shares. All proposals, including the election of directors and the appointment of KPMG LLP as auditors, received majority approval. Key director votes showed strong support, with Miguel Martin receiving 92.71% approval. Additionally, shareholders endorsed a non-binding advisory on executive compensation and renewed the shareholder rights plan. Complete voting results will be filed on SEDAR.

Positive

• All proposals at the Annual General Meeting were approved by a majority, indicating shareholder confidence.
• Strong director election results, with Miguel Martin receiving 92.71% of votes in favor.

Negative

• None.

NASDAQ | TSX: ACB

EDMONTON, AB, Nov. 12, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held on Friday, November 12, 2021 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 60,616,648, representing 30.6% of Aurora's issued and outstanding common shares.

All of the matters put forward before shareholders for consideration and approval, as set out in the Company's Management Information Circular dated September 28, 2021, were approved by the requisite majority of votes cast at the Meeting. The details of the voting results for the election of directors are set out below:

Nominee	Votes For	Votes Withheld
Ron Funk	10,642,852 (80.64%)	2,555,816 (19.36%)
Miguel Martin	12,237,085 (92.71%)	961,584 (7.29%)
Michael Singer	12,159,429 (92.13%)	1,039,240 (7.87%)
Norma Beauchamp	10,661,885 (80.78%)	2,536,784 (19.22%)
Margaret Shan Atkins	10,689,801 (80.99%)	2,508,868 (19.01%)
Theresa Firestone	12,249,943 (92.81%)	948,726 (7.19%)
Adam Szweras	10,527,087 (79.76%)	2,671,582 (20.24%)
Lance Friedmann	12,195,930 (92.40%)	1,002,738 (7.60%)

Shareholders also approved the following matters:

• appointment of KPMG LLP as auditors of the Company for the ensuing year;
• a non-binding advisory resolution on the Company's approach to executive compensation; and
• renewal of the Company's shareholder rights plan.

The Company will file a report of voting results on all resolutions voted on at the Meeting under its profile on www.sedar.com.

About Aurora:

Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Pedanios, Whistler, Reliva and KG7 CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn.

Aurora's common shares trade on the TSX and NASDAQ under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index. 

Forward-looking Information 

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable.  Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer  sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 27, 2021 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.sec.gov.  The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-announces-results-of-2021-annual-general-meeting-301423406.html

SOURCE Aurora Cannabis Inc.

FAQ

What were the voting results of Aurora Cannabis' Annual General Meeting on November 12, 2021?

Aurora Cannabis' Annual General Meeting on November 12, 2021, resulted in all proposals being approved, with 60,616,648 shares represented, which is 30.6% of total outstanding shares.

Who received the highest approval in the director election during Aurora Cannabis' Annual General Meeting?

Miguel Martin received the highest approval in the director election, with 92.71% of the votes in favor.

What significant matters were approved at the Aurora Cannabis Annual General Meeting?

Key approvals included the election of directors, the appointment of KPMG LLP as auditors, a non-binding advisory on executive compensation, and the renewal of the shareholder rights plan.